Omni Health Inc (OMHE)

[mattsinvestmentclub]

the pharmacy revenue of OMHE, but OMHE is looking to broaden the scope of revenue $OMHE
hrough some strategic partnerships and opportunities. $OMHE
OMHE is looking to expand into cannabis and biotech, developing anti-aging creams and lotions." $OMHE
Omni Health, Inc. Converts 62% (600 Million Common Shares) $OMHE
Restructuring $OMHE
a cannabis and biotech pharmaceutical company, specializing in health and wellness products utilizing cannabis $OMHE
and biotech engineering, filed a Form 8K today to inform its shareholders of the restructuring of OMHE. Andrey Soloviev, $OMHE
the company's Chief Executive Officer and Chairman of the Board has converted 556,890,449 shares of common stock $OMHE
into 5,600,000 Series A Preferred Stock. In addition, 50,000,000 shares of common stock are to be converted into 5,000,000 shares $OMHE
The actions reduce the outstanding common stock of OMHE by 62% to 368,938,292 shares of common stock. $OMHE
Mr. Soloviev stated, "Recognizing the continued evolution of our anti-aging cream business, $OMHE
and our strategy to grow and enter into the cannabis and biotech platforms, $OMHE
we conducted a thorough review of our corporate structure to optimize our support of both existing and future operations." $OMHE
More
This allows our shareholders the ability to look into the future without concern of dilution $OMHE
from these shares being available to be sold into the market." $OMHE
Omni Health Receives $1 Million in Bridge Financing as Part of $6 Million Capital Raise Plan $OMHE
a vertically integrated healthcare company dedicated to the development of pharmaceutical, anti-aging products, $OMHE
and cannabis biotech engineering, announced today that it has received $1,000,000 in financing through private investors exempt $OMHE
from registration and restricted under Rule 144 of the Securities Exchange Act of 1933. $OMHE
The financing will allow OMHE to accelerate planned growth into key health technology fields.
and cannabis biotech engineering, announced today the grand opening of its state $OMHE
to develop superior quality intellectual properties with rapid deployment to market and capitalize $OMHE
and cannabis biotech engineering, announced that Lawrence E. Samuels, MD, has joined its Scientific Advisory Board (SAB). $OMHE
The SAB will work closely with the OMHE management team to advance the Company's product development programs. $OMHE
said Andrey Soloviev, OMHE's Chief Executive Officer. "His ongoing technical expertise $OMHE
in his medical field, founded RX Systems PF in 1966 and is highly knowledgeable in pH-balanced, Glypoic Complex-based products, $OMHE
Dr. Samuels will provide access to a lucrative niche market of doctors' offices and medical facilities. $OMHE
CEO Andrey Soloviev further noted, "Our plan for growth accelerates with the synergy created by our scientific board, $OMHE
Omni Health, Inc. Announces Roll Out of Anti-Aging Product Line $OMHE
Dr. Lawrence Samuels, a member of the Scientific Advisory Board of OMHE, $OMHE
Celeb Cream, Inc., expects to bring more than $2M in revenue to OMHE over the course of the next year, $OMHE
increasing OMHE projections for this fiscal year to more than $10M in revenue. $OMHE
Andrey Soloviev, OMHE Chief Executive Officer, stated, "When we acquired Malecon Pharmacy approximately one year ago, $OMHE
The roll-up of Celeb Cream into OMHE was without any shareholder dilution. $OMHE
and the American Society for Dermatologic Surgery.